Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $144.5 million versus the consensus estimate of $141.81 million.

GUIDANCE:

Evolent Health sees Q3 2018 revenue of $570-585 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.